Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

PHASE2CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

October 12, 2023

Study Completion Date

October 25, 2023

Conditions
Diabetic Peripheral Neuropathy
Interventions
DRUG

Suzetrigine

Tablets for oral administration.

DRUG

Pregabalin

Capsules for oral administration.

DRUG

Placebo (matched to SUZ)

Placebo matched to SUZ for oral administration.

DRUG

Placebo (matched to pregabalin)

Placebo matched to pregabalin for oral administration.

Trial Locations (50)

10017

Synexus Clinical Research- New York, New York

27103

The Center for Clinical Research, Winston-Salem

27410

Triad Clinical Trials, Greensboro

28303

Carolina Institute for Clinical Research, Fayetteville

29118

South Carolina Clinical Research, Orangeburg

29406

Clinical Trials of South Carolina - Charleston, Charleston

29621

Synexus Clinical Research- Anderson, Anderson

30030

Accel Research Sites - Neurostudies, Decatur

32003

Fleming Island Center for Clinical Research, Fleming Island

32205

Westside Center for Clinical Research, Jacksonville

32751

Accel Research Sites - Maitland, Maitland

33137

Suncoast Research Associates, Miami

33777

Accel Research Sites - Tampa, Largo

33912

AMR Fort Myers (The Clinical Study Center), Fort Myers

35211

Synexus Clinical Research US - Birmingham, Birmingham

36207

Pinnacle Research Group, LLC, Anniston

44122

Velocity Clinical Research - Cleveland, Cleveland

45236

Synexus - Cincinnati, Cincinnati

47714

Synexus Clinical Research - Evansville, Evansville

48126

Revival Research Institute, Dearborn

60422

Healthcare Research Network - Chicago, Flossmoor

63042

Healthcare Research Network - Hazelwood, Hazelwood

63141

Synexus Clinical Research US - St. Louis, St Louis

67042

AMR El Dorado, El Dorado

67114

AMR Newton, Newton

67207

AMR Wichita East, KS, Wichita

71201

Clinical Trials of America, LLC, Monroe

77521

Inquest Clinical Research, Baytown

80918

Lynn Institute of the Rockies, Colorado Springs

83642

Velocity Clinical Research - Boise (Advanced Clinical Research), Meridian

84107

Wasatch Clinical Research, Salt Lake City

85020

Synexus Clinical Research US - Phoenix West, Phoenix

89052

Synexus Clinical Research - Henderson, Henderson

90806

Long Beach Clinical Trials Services, Inc., Long Beach

92220

Velocity Clinical Research - Banning, Banning

92780

University Clinical Investigators, Tustin

97504

Velocity Clinical Research - Medford, Medford

33009-4427

Velocity Clinical Research - Hallandale Beach, Hallandale

32806-1041

Synexus - Orlando, Orlando

32162-7116

Synexus - The Villages, The Villages

02115

Brigham and Women's Hospital (BWH) - Translational Pain Research, Boston

02747

Boston Neuro Research Center, LLC, North Dartmouth

02451

Boston PainCare Center, Waltham

63303-3041

StudyMetrix Research, LLC, City of Saint Peters

64114-4866

AMR Kansas City, Kansas City

08009

Hassman Research Institute, Berlin

02818

Velocity Clinical Research - Providence, East Greenwich

75234-7858

Synexus - Dallas, Dallas

78229-4801

Diabetes & Glandular Disease Clinic, P.A, San Antonio

98007-4209

Northwest Clinical Research Center (NWCRC), Bellevue

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY